Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil effect-site concentration for smooth emergence after double-lumen tube extubation
ChiCTR2100054230Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Dec 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remifentanil in None (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: EC90. Started Dec 2021; status: recruiting.
02
Drugs
remifentanil
Beyond the preview
Go deeper on ChiCTR2100054230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054230.